conversational-ai-leader-senseforth.ai-raises-$14-million-from-fractal

Conversational AI Leader Senseforth.ai Raises $14 million from Fractal

 

Conversational AI leader Senseforth.ai today announced a $14 million investment from Fractal (fractal.ai), a global provider of artificial intelligence and analytics solutions to Fortune 500® companies. This investment will help Senseforth.ai scale and expand its footprint across Fractal’s clients globally. This investment also strengthens Fractal’s conversational AI offerings as it advances on its mission to power every human decision in the enterprise.

Senseforth.ai’s patented and award winning zero-code platform A.ware automates customer experience across digital touchpoints for global enterprises. It is estimated that by 2022, 30% of customer experiences will be handled by conversational AI, up from 3% in 2017. A.ware makes it easy to build, train, deploy, and scale conversational AI solutions to drive revenue, reduce costs and increase operational efficiency.

Shridhar Marri, CEO and Co-Founder of Senseforth, said, “This strategic investment creates a new growth blueprint for Senseforth.ai. We are thrilled to deliver on our vision “to make technology humanlike”, enabling continuous Human-AI interaction, transforming complex business processes.” He added, “We can now scale talent, accelerate growth, make more investments in R&D, and create incredible value for our clients.”

Announcing the strategic investment, Fractal’s Co-Founder, Group Chief Executive and Vice Chairman, Srikanth Velamakanni said, “Senseforth.ai’s founders Shridhar, Krishna and Ritesh have built a great team and a robust platform that’s deployed at scale with marquee clients like HDFC Bank. Senseforth’s technology is ahead of the competition, especially as evidenced by their performance benchmark on the leaderboard of Stanford Question Answering Dataset (SQuAD) 2.0.” Srikanth added, “We are excited to partner with the Senseforth.ai team to contribute to their next phase of growth.”

“We are inspired by Senseforth.ai’s work with the government of India to remove technology barriers in accessing citizen services for 700 million internet users through conversational AI. We are delighted to partner with Senseforth and expand conversational AI solutions to our clients,” said Pranay Agrawal, Fractal’s Co-founder and Chief Executive Officer.

Krishna Kadiri, Chief AI Officer and Co-Founder of Senseforth, said, “Senseforth has a robust R&D and innovation culture and has already made its mark in the global ML benchmarks. This investment will help us enhance our deep learning capabilities and embed advanced cutting-edge research into A.ware.”

Don Vadakan, Chief Sales Officer at Fractal, said, “Senseforth’s industry agnostic, multi-experience AI platform will drive next-generation digital solutions. We are excited to deliver powerful use cases across industries for both large and mid-size enterprises with A.ware from Senseforth.”

Ritesh Radhakrishnan, CTO, and Co-Founder of Senseforth, said, “At Senseforth.ai, we have built A.ware, one of the most powerful and comprehensive Conversational AI Platforms in the market today. A.ware is already automating billions of conversations for enterprises across the world. This investment will help us further strengthen our technology foundation and scale our platform and products to become the undisputed market leader in the Conversational AI space.”

powerbridge-technologies-co,-ltd.-(pbts)-expanding-its-blockchain-business-to-engage-in-cryptocurrency-mining

Powerbridge Technologies Co., Ltd. (PBTS) Expanding its Blockchain Business to Engage in Cryptocurrency Mining

 

Powerbridge Technologies Co., Ltd. (Nasdaq: PBTS) (“Powerbridge” or the “Company”) is pleased to announce that Powerbridge plans to invest and engage in the cryptocurrency mining for Bitcoin (BTC) and Ethereum (ETH) with planned operations globally. The Company has assembled a team of industry veterans in cryptocurrency and technology to support the development and growth of its digital asset business.

Stewart Lor, President and Chief Financial Offer commented: We are optimistic about the positive outlook of the cryptocurrency market. Our initiative to engage in crypto mining is an important part of our overall blockchain strategy. We strive to continually build a clean energy based BTC and ETH mining network globally. We believe our crypto mining business will generate valuable digital assets that help accelerate the Company’s growth.

spoke-is-working-together-with-qualcomm-technologies-to-transform-safety-for-bicyclists-and-light-mobility-users

Spoke is Working Together with Qualcomm Technologies to Transform Safety for Bicyclists and Light Mobility Users

 

Spoke, a mobility platform for safety, connectivity and rich rider experiences, today announced plans to bring connected technology to vulnerable road users (VRUs), including bicyclists and scooter riders, using Cellular Vehicle-to-Everything (C-V2X) solutions from Qualcomm Technologies, Inc. A first-of-its-kind, the Spoke hardware and software suite, which features the C-V2X solutions, is designed to be the industry’s first reliable, robust connected system to offer secure, direct communication for contextual awareness and alerts between drivers and riders, enhancing safety for VRUs.

Reimagining the form factor, which has been engineered previously for automotive, Spoke’s new hardware solution is designed to enable vehicles to identify VRUs using the same C-V2X technology used in vehicles. The Spoke solution is intended to provide direct communication between road users, vehicles and roadside infrastructure without the need for a cellular network, delivering the level of dependable real-time information critical for safety applications. This capability provides critical augmentation to other Advanced Driver Assistance Systems (ADAS) sensors, such as cameras, radar, and Light Detection and Radar (LIDAR).

“This is game-changing connectivity for both safety and for the mobility experience overall,” said Jarrett Wendt, Spoke CEO. “For the first time, Spoke will provide dedicated hardware and software, what we refer to as vulnerable road user-to-everything (VRU2X), to unlock V2X communication to the most vulnerable users. VRU2X unlocks location accuracy through direct digital communication that connects all users anonymously to each other and to the infrastructure.”

C-V2X is uniquely designed to offer highly reliable, low-latency direct communication between VRUs, vehicles and roadside infrastructure in the 5.9 GHz ITS spectrum without reliance on cellular networks. C-V2X can provide highly reliable, low-latency broadcast to support advanced safety use cases and enhanced vehicle automation. C-V2X is also globally compatible with 5G networks and cloud-based APIs, enabling numerous capabilities with artificial intelligence/machine learning to enhance safety features.

C-V2X direct communication is an essential technology for safety and mobility applications, helping to reduce crashes and incident-related congestion for more efficient traffic flow.

Spoke is working with a number of stakeholders, including Qualcomm Technologies and vehicle, bicycle, scooter and motorcycle OEMs, for maximum scale, adoption and safety impact. Spoke’s portfolio, which will also include modem-based communications, will be launching with their OEM bicycle, motorcycle and scooter partners in 2022.

“Spoke was born from a passion to reduce rider vulnerability, prevent crashes and save lives using an innovative adaption of technology that is available today. There is tremendous opportunity to deliver a safer, richer, more dynamic trip experience,” added Wendt. “We are confident that through our work with various stakeholders, including Qualcomm Technologies, we will be able to reach our goal of including the most vulnerable road users in the intelligent transportation ecosystem equation. We expect Qualcomm Technologies’ industry-leading C-V2X technologies to elevate Spoke’s safety and mobility portfolio, helping us all arrive home safely.”

northstar-and-japan-space-imaging-join-forces-to-promote-commercial-space-situational-awareness-services-to-japan

NorthStar and Japan Space Imaging join forces to promote commercial Space Situational Awareness services to Japan

 

NorthStar Earth & Space of Montreal, Canada, has entered into an agreement with Japan Space Imaging Corporation (JSI) to tailor product offerings for Japanese customers based on NorthStar’s space-based precision Space Situational Awareness (SSA) services.  The agreement designates JSI act as Authorized Marketing Representative for NorthStar’s suite of services with the government of Japan and with Japanese commercial entities.

JSI and NorthStar will promote valuable space information and intelligence services to Japanese government and commercial customers to safely navigate in an ever contested and congested space environment.  Together, the two companies desire to greatly enhance current capabilities to ensure safe access to and operations in space and notably to protect the global satellite community from collisions.

“NorthStar is proud to partner with Japan Space Imaging Corporation- to tailor our services to Japanese Customers. As an established partner of the global space community, JSI is the ideal partner for NorthStar to promote the safety, security and sustainability of the space environment for a host of Japanese stakeholders” said Stewart Bain, CEO of NorthStar Earth & Space.

Commercial space is forecast to grow into a $2.7 trillion industry. New satellites and planned mega-constellations are launching into an environment ever more congested with traffic and space debris. Increased risks must be mitigated with precision information that fuel better Space Situational Awareness (SSA) services.  The combination of NorthStar’s Space Information and Intelligence services (Si2) and JSI’s established expertise will ensure Japanese commercial and government customers have access to NorthStar services to ensure safe access to space.

“JSI is delighted to partner with NorthStar to promote their SSA services in Japan. We feel enthusiastic to contribute to our customers in Japan and their indispensable missions with NorthStar’s unique space-based SSA capabilities powered by their cutting-edge processing algorithms” said Koji Ueda, CEO and President of Japan Space Imaging Corporation.

ziflow-wins-“best-marketing-resource-management-platform”-in-2021-martech-breakthrough-awards

Ziflow Wins “Best Marketing Resource Management Platform” in 2021 MarTech Breakthrough Awards

 

Ziflow, the industry’s leading creative review and approval solution for agencies and brands, announced today that it has been selected as the winner of the “Best Marketing Resource Management Platform” award in the 2021 MarTech Breakthrough Awards program. The awards are conducted by MarTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global marketing, sales and advertising technology industry today.

Ziflow is the only standalone online proofing solution on the market that offers a secure, enterprise-ready environment in which creative content can be reviewed from anywhere, on any device, with any workflow. The platform’s resource-centric approach to creative review and approval allows stakeholders at every level of the organization to quickly overcome complex review and approval workflow challenges and support more effective and efficient team feedback. Rich annotation and markup tools, real-time collaboration capabilities, and automated workflows simplify the entire review and approval process, mitigate bottlenecks, and support multi-region team communication.

“Ziflow is honored to be recognized in this year’s MarTech Breakthrough Awards; the win acts as a testament to the value that Ziflow strives to provide to the MarTech industry and its customers,” said CEO and Co-Founder, Anthony Welgemoed. “With a heightened need for automated workflow solutions during the pandemic brought on by work-from-home environments and, separately, the accelerated delivery of global campaigns, we are now a critical tool for close to one million users that rely on Ziflow every day to get real, actionable results. In this coming year, we are eager to continue our rapid growth, and extend our market leadership for online proofing.”

Ziflow acts as a single source of truth for leading brands and agencies that require a more streamlined approach to online proofing. The platform automates a number of essential team functions such as the creation of proofs, staged review, project and team productivity trend insights, updates and reminders for tracking purposes and corresponding alarms, and much more. It also enhances team and client collaboration through the integration of associated feedback and approvals that were previously accomplished via hallway conversations, emails and printouts, and other inefficient methods. Ziflow provides creative teams with a fully digital approach to embrace and enable today’s remote working scenarios – significantly improving overall workflow productivity by up to 48% from these traditional processes.

“Marketing and creative teams are remotely producing more content for more channels than ever before, and these teams need a simple and powerful solution that makes remote collaboration seamless and efficient,” said James Johnson, Managing Director at MarTech Breakthrough. “Ziflow’s online proofing solution delivers on this need with a “breakthrough” platform that helps marketing and creative teams overcome complex content workflow review and approval challenges. We extend our sincere congratulations to the entire Ziflow team on taking home the ‘Best Marketing Resource Management Platform’ award this year.”

The MarTech Breakthrough Awards honor excellence and recognize innovation, hard work, and success in a range of marketing, sales, and advertising technology related categories, including marketing automation, market research and customer experience, AdTech, SalesTech, marketing analytics, content, and social marketing, and mobile marketing. This year’s program attracted more than 2,850 nominations from over 17 different countries throughout the world.

technology-investments-will-help-oncology-practices-succeed-in-value-based-care

Technology Investments will Help Oncology Practices Succeed in Value-based Care

 

Community oncology practices are continuing to adapt to value-based reimbursement models as the Centers for Medicare and Medicaid Services (CMS) prepares to transition from the Oncology Care Model (OCM) to the Oncology Care First (OCF) model in 2022. While the full details of this transition are still pending, OCF is expected to include more practices than OCM – and may create similar challenges for oncologists and administrators when it comes to achieving financial performance.

Frost & Sullivan’s latest article, From OCM to OCF: Lessons Learned and What’s Next, recaps the key takeaways from a recent discussion among oncology practices that participated in OCM about preparing for the future of value-based care. Sponsored by Cardinal Health Specialty Solutions, the discussion highlighted the need for internal champions, data transparency, and additional staff to follow up with and triage patients who may be experiencing adverse events. Participating practice leaders also offered recommendations to community oncology practices that may be embarking on value-based reimbursement for the first time.

To download the complimentary white paper, please visit: http://frost.ly/62s

“When it comes to succeeding in value-based care, it is essential for oncology practices to have a champion in an administrative role. This will ensure that the practice has a person who sees the whole picture, speaks the clinical language, and drives the overall operational change,” observed Patrick Riley, Healthcare & Life Sciences, Industry Principal at Frost & Sullivan. “It is also vital to add or assign staff to regularly follow up with patients and proactively address health issues before they lead to an ER visit.”

“To make the best use of their staff and resources and ensure that patients receive optimal care, practices are increasingly reliant on predictive data and analytics,” noted Amy Valley, Vice President, Clinical Strategy at Cardinal Health Specialty Solutions. “Artificial intelligence-enabled technology can be used to deliver actionable insights to help identify patients at high risk of mortality, ER visits, and hospital readmission, and provide them with early interventions. Data transparency will not only improve patient outcomes but also help practices achieve their financial targets.”

Community oncology practices need to prepare for the transition to OCF in 2022. After evaluating their current data trends, costs and care outcomes, practices should consider the following steps for a successful transition to this next value-based payment model:

  • Be better prepared to take on more risks.
  • Establish a baseline metric from current performance periods and then adjust as needed to address areas of opportunity.
  • Invest in the resources and technology necessary to monitor and pivot to meet the demands of the evolving value-based care landscape.
symphony-industrialai-appoints-barry-johnson-president-of-digital-manufacturing

Symphony IndustrialAI Appoints Barry Johnson President of Digital Manufacturing

 

Symphony Industrial AI announced today the appointment of Barry Johnson as president of Digital Manufacturing. The move supports Symphony IndustrialAI’s rapid growth and its expansion into enterprise AI solutions for plant operations, visibility, and performance. The announcement comes on the heels of two additional key hires for the Symphony IndustrialAI’s digital manufacturing division, Vice President of Products Prashant Jagarlapudi and Chief Revenue Officer Ron Posey.

Johnson is an experienced senior executive with more than 25 years of demonstrated success in the industrial software sector, driving revenue growth and improving business performance internationally. Johnson previously served in multiple executive roles at Rockwell Automation, including global vice president of software sales. Before Rockwell, Barry held numerous software roles at GE, driving growth organically and inorganically.

“Enterprise AI in industrial applications has reached an inflection point, and Barry and his team are on the leading edge,” said Symphony IndustrialAI Chief Executive Officer Dominic Gallello. “As a transformational change leader, Barry plays a key role in fueling growth through close work with sales, product management, engineering, and professional services teams. Prashant and Ron bring added power to our work in digital manufacturing and Enterprise AI.”

“With the launch of the EurekaAI industrial platform and Symphony IndustrialAI’s digital manufacturing solutions, we are working with leaders across industrial applications to make strides in enterprise AI adoption,” said Johnson. “2021 is a year of immense transformation as we lay the digital foundation for the success of tomorrow’s industrial and manufacturing champions. There’s no team better suited to accelerate this evolution than Symphony IndustrialAI.”

These appointments follow Symphony IndustrialAI’s introduction of the end-to-end Eureka AI platform for manufacturing and the acquisition of Savigent.

technology-investments-will-help-oncology-practices-succeed-in-value-based-care

Technology Investments will Help Oncology Practices Succeed in Value-based Care

 

Community oncology practices are continuing to adapt to value-based reimbursement models as the Centers for Medicare and Medicaid Services (CMS) prepares to transition from the Oncology Care Model (OCM) to the Oncology Care First (OCF) model in 2022. While the full details of this transition are still pending, OCF is expected to include more practices than OCM – and may create similar challenges for oncologists and administrators when it comes to achieving financial performance.

Frost & Sullivan’s latest article, From OCM to OCF: Lessons Learned and What’s Next, recaps the key takeaways from a recent discussion among oncology practices that participated in OCM about preparing for the future of value-based care. Sponsored by Cardinal Health Specialty Solutions, the discussion highlighted the need for internal champions, data transparency, and additional staff to follow up with and triage patients who may be experiencing adverse events. Participating practice leaders also offered recommendations to community oncology practices that may be embarking on value-based reimbursement for the first time.

To download the complimentary white paper, please visit: http://frost.ly/62s

“When it comes to succeeding in value-based care, it is essential for oncology practices to have a champion in an administrative role. This will ensure that the practice has a person who sees the whole picture, speaks the clinical language, and drives the overall operational change,” observed Patrick Riley, Healthcare & Life Sciences, Industry Principal at Frost & Sullivan. “It is also vital to add or assign staff to regularly follow up with patients and proactively address health issues before they lead to an ER visit.”

“To make the best use of their staff and resources and ensure that patients receive optimal care, practices are increasingly reliant on predictive data and analytics,” noted Amy Valley, Vice President, Clinical Strategy at Cardinal Health Specialty Solutions. “Artificial intelligence-enabled technology can be used to deliver actionable insights to help identify patients at high risk of mortality, ER visits, and hospital readmission, and provide them with early interventions. Data transparency will not only improve patient outcomes but also help practices achieve their financial targets.”

Community oncology practices need to prepare for the transition to OCF in 2022. After evaluating their current data trends, costs and care outcomes, practices should consider the following steps for a successful transition to this next value-based payment model:

  • Be better prepared to take on more risks.
  • Establish a baseline metric from current performance periods and then adjust as needed to address areas of opportunity.
  • Invest in the resources and technology necessary to monitor and pivot to meet the demands of the evolving value-based care landscape.
amind-joins-argano-to-build-quote-to-cash-solutions-that-make-businesses-run-better

aMind Joins Argano to Build Quote-to-Cash Solutions that Make Businesses Run Better

 

Argano announced today aMind Solutions will join its platform to build omni-channel enabled quote-to-cash solutions that are integral to the digital foundations that make businesses run better.

Headquartered in Alamo, California, go-to Salesforce partner aMind Solutions was founded in 2005 to deliver elegant, mission critical, high transaction throughput configure, price, quote (CPQ) and billing applications across sales, partners, field service and eCommerce channels. The company’s highly satisfied and 100 percent referenceable client base has been achieved by their laser focus on customer success.

“Quote to cash success requires aligning the breadth, depth and nuance of platform capabilities with core business processes while meeting expectations of a best-in-class customer experience,” said Billy Hunt, President of aMind Solutions. “We take our responsibility as frictionless quote to cash experts and our track record of success seriously, which is a key reason why the fit with Argano’s all-star results-oriented culture is excellent.”

Argano brings together specialized firms on an integrated platform. This model offers clients access to a unified set of unique business and technology solutions that are core to strong Digital Foundation including:

  • Enabling sales and services to deliver frictionless customer experiences that optimize revenue.
  • Architecting integrated logistics and supply chains that are resilient and flexible.
  • Delivering agile planning systems and analytics that drive a more strategic approach to financial management.
  • Implementing ERP systems and processes that improve data visibility and integrity across core operations.
  • Building workforce solutions that enhance employee engagement, productivity and value.

“aMind is a leader in quote-to-cash, successfully delivering multi-channel solutions that stay ahead of, and in fact define the future in a world challenged by accelerating complexity,” said Argano Group CEO, and former Co-CEO of PublicisSapient, Chip Register. “High-value solutions require a strong empirical approach to prioritizing features that deliver the greatest business benefit. aMind’s expertise deepens Argano’s ability to support complex businesses from commerce to cash to close.”

Five companies precede aMind Solutions in joining the Argano platform. SCMO2 is a leader in supply chain planning and transformation. Arbela Technologies brings expertise in ERP, CRM and analytics solutions. ArganoKeste is an award-winning technology services firm focused on commerce to cash solutions in the B2B space. ArganoInterRel brings unmatched experience in enterprise performance management (EPM) and business intelligence (BI) software. And, ArganoUV brings world-class design and technology talent to the platform, delivering ground-breaking commerce experiences for some of the world’s leading B2C brands.

diabetes-devices-market-size-worth-$446-billion-by-2028-|-cagr-66%:-grand-view-research,-inc.

Diabetes Devices Market Size Worth $44.6 Billion By 2028 | CAGR 6.6%: Grand View Research, Inc.

 

The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.

Key Insights & Findings:

  • North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches
  • By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate
  • In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage
  • In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements
  • In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage
  • In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices
  • By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies
  • By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment
  • The leading players present in the diabetes devices market are Medtronic plc; Abbott Laboratories; F.Hoffmann-La-Ltd; Bayer AG; Lifescan, Inc.; B Braun Melsungen AG; Lifescan, Inc.; Dexcom Inc.; Insulet Corporation; Ypsomed Holdings; Companion Medical; Sanofi; Valeritas Holding Inc.; Novo Nordisk; Arkray, Inc.; among others

Read 140 page market research report, “Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use (Hospitals, Homecare), By Region, And Segment Forecasts, 2021 – 2028“, by Grand View Research

According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.

In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.

Grand View Research has segmented the global diabetes devices market on the basis of type, distribution channel, end-use, and region:

  • Diabetes Devices Type Outlook (Revenue, USD Million, 2016 – 2028)
    • BGM Devices
      • Self-Monitoring Devices
        • Blood Glucose Meters
        • Testing Strips
        • Testing Strips
      • Continuous Glucose Monitoring Devices
        • Sensors
        • Transmitters
        • Receiver
    • Insulin Delivery Devices
      • Pumps
      • Pens
      • Syringes
      • Jet Injectors
  • Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 – 2028)
    • Hospital pharmacies
    • Retail Pharmacies
    • Diabetes Clinics/Centers
    • Online Pharmacies
    • Others
  • Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 – 2028)
    • Hospital
    • Homecare
    • Diagnostic Centers
  • Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 – 2028)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Czech Republic
      • Poland
      • Switzerland
      • Turkey
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Vietnam
      • Philippines
      • Malaysia
      • Indonesia
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Oman

List of Key Players of Diabetes Devices Market

  • Medtronic plc
  • Abbott Laboratories
  • F.Hoffmann-La-Ltd.
  • Bayer AG
  • Lifescan, Inc.
  • B Braun Melsungen AG
  • Dexcom Inc.
  • Insulet Corporation
  • Ypsomed Holdings
  • Companion Medical
  • Sanofi
  • Valeritas Holding Inc.
  • Novo Nordisk
  • Arkray, Inc.

Check out more studies related to the Global Medical Devices Industry, conducted by Grand View Research:

  • Pessary Market  The global pessary market size is expected to reach USD 547.2 million by 2028, according to a new report by Grand View Research, Inc.
  • Exoskeleton Market  The global exoskeleton market size is expected to reach USD 953.1 million by 2028, according to a new report by Grand View Research, Inc
  • Microneedling Market  The global microneedling market size is expected to reach USD 992.49 million by 2028, registering a CAGR of 7.9% over the forecast period, according to a new report by Grand View Research, Inc.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports